Date | Event | Description |
---|---|---|
4 May 2020 | Amended | Correction: Three of the included studies in this review assessed a probiotic formulation known as VSL#3. The probiotic formulation that was assessed in these studies is now known by the generic name ’De Simone Formulation’. To the best of our knowledge, there are no randomized trials that have assessed the current product known as VSL#3 in people with UC. The current product known as VSL#3 is not the same formulation as the original product invented by Professor De Simone. De Simone Formulation is available under the brand names Visbiome in the USA and Vivomixx in the EU. |